Xenon Pharmaceuticals Inc. (XENE) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2013: $30.37M2014: $14.64M2015: $2.92M2016: $3.59M2017: $10.19M2018: $19.13M2019: $55.72M2020: $17.83M2021: $21.97M2022: $32.65M2023: $36.88M2024: $43.24M2025: $51.40M$51.40M
2013Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$51.40M+18.9%
2024$43.24M+17.2%
2023$36.88M+12.9%
2022$32.65M+48.6%
2021$21.97M+23.2%
2020$17.83M-68.0%
2019$55.72M+191.2%
2018$19.13M+87.8%
2017$10.19M+184.1%
2016$3.59M+23.0%
2015$2.92M-80.1%
2014$14.64M-51.8%
2013$30.37M